CD8A and hepatocellular carcinoma: Szoor and colleagues used MSCs that expressed bispecific T-cell splicing agents (GPC3-ENG) targeting Glypican 3 (GPC3) and CD3, to direct GPC3-specific CD4 + T helper cells and CD8 + CTLs towards the GPC3-expressing HCC cells.